<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Inicet Nov 2024 Mock Test 2   27 10 2024   2024 10 27</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Inicet Nov 2024 Mock Test 2   27 10 2024   2024 10 27</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                200 Questions | 800 Total Marks | 210 min Duration | ~63.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 200 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 210 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 200</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Inicet Nov 2024 Mock Test 2   27 10 2024   2024 10 27 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 200</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 200 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 27-year-old man presents to the emergency department with profuse, watery diarrhea, severe dehydration, and vomiting for the past 24 hours. Physical examination reveals signs of dehydration, including dry mucous membranes and decreased skin turgor. Stool examination confirms the presence of Vibrio cholerae. Which of the following cellular structures is disrupted by the cholera toxin to cause watery diarrhea?", "options": [{"label": "A", "text": "Intercalated discs", "correct": false}, {"label": "B", "text": "Macula densa", "correct": false}, {"label": "C", "text": "Zonula occludens", "correct": true}, {"label": "D", "text": "Hemidesmosomes", "correct": false}], "correct_answer": "C. Zonula occludens", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-155159.jpg"], "explanation": "<p><strong>Ans. C) Zonula occludens</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Cholera toxin acts by increasing cAMP in intestinal cells, leading to chloride and water secretion. The zonula occludens (tight junctions) are disrupted, contributing to increased intestinal permeability and profuse, watery diarrhea. Preventing dehydration is crucial in the management of cholera.</li><li>âž¤ Cholera toxin acts by increasing cAMP in intestinal cells, leading to chloride and water secretion.</li><li>âž¤ Cholera toxin</li><li>âž¤ cAMP</li><li>âž¤ The zonula occludens (tight junctions) are disrupted, contributing to increased intestinal permeability and profuse, watery diarrhea.</li><li>âž¤ zonula occludens</li><li>âž¤ Preventing dehydration is crucial in the management of cholera.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 7-year-old child with Lennox-Gastaut syndrome is experiencing frequent multifocal seizures and has a characteristic <2.5 Hz spike-and-wave pattern on EEG. The neurologist decides to start an antiepileptic medication that can also be used for migraine prophylaxis and for managing alcohol cravings in adults. Which of the following drug is the neurologist thinking to start?", "options": [{"label": "A", "text": "Valproate", "correct": false}, {"label": "B", "text": "Ethosuximide", "correct": false}, {"label": "C", "text": "Topiramate", "correct": true}, {"label": "D", "text": "Rufinamide", "correct": false}], "correct_answer": "C. Topiramate", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Topiramate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Topiramate is effective in treating Lennox-Gastaut syndrome and is also used for migraine prophylaxis and to reduce alcohol cravings . While valproate is also used in Lennox-Gastaut syndrome and migraine prevention, it is not typically used for managing alcohol cravings . Ethosuximide is primarily for absence seizures , and rufinamide is limited to seizures without additional benefits for migraines or alcohol use disorders.</li><li>âž¤ Topiramate is effective in treating Lennox-Gastaut syndrome and is also used for migraine prophylaxis and to reduce alcohol cravings .</li><li>âž¤ Topiramate</li><li>âž¤ Lennox-Gastaut syndrome</li><li>âž¤ migraine prophylaxis</li><li>âž¤ alcohol cravings</li><li>âž¤ While valproate is also used in Lennox-Gastaut syndrome and migraine prevention, it is not typically used for managing alcohol cravings .</li><li>âž¤ valproate</li><li>âž¤ alcohol cravings</li><li>âž¤ Ethosuximide is primarily for absence seizures , and rufinamide is limited to seizures without additional benefits for migraines or alcohol use disorders.</li><li>âž¤ Ethosuximide</li><li>âž¤ absence seizures</li><li>âž¤ rufinamide</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Match the following drugs with its corresponding mechanisms of action:", "options": [{"label": "A", "text": "A-3, B-4, C-2, D-1", "correct": true}, {"label": "B", "text": "A-1, B-2, C-4, D-3", "correct": false}, {"label": "C", "text": "A-3, B-2, C-1, D-4", "correct": false}, {"label": "D", "text": "A-4, B-1, C-3, D-2", "correct": false}], "correct_answer": "A. A-3, B-4, C-2, D-1", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-160306.jpg"], "explanation_images": [], "explanation": "<p><strong>Ans. A) A-3, B-4, C-2, D-1</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Adalimumab is a TNF-alpha antagonist used in autoimmune conditions like rheumatoid arthritis. Albiglutide is a GLP-1 agonist used for glycemic control in type 2 diabetes. Alogliptin is a DPP-4 inhibitor that prolongs incretin activity to manage diabetes. Apremilast is a PDE-4 inhibitor used to reduce inflammation in psoriasis and psoriatic arthritis .</li><li>âž¤ Adalimumab is a TNF-alpha antagonist used in autoimmune conditions like rheumatoid arthritis.</li><li>âž¤ Adalimumab</li><li>âž¤ TNF-alpha antagonist</li><li>âž¤ Albiglutide is a GLP-1 agonist used for glycemic control in type 2 diabetes.</li><li>âž¤ Albiglutide</li><li>âž¤ GLP-1 agonist</li><li>âž¤ Alogliptin is a DPP-4 inhibitor that prolongs incretin activity to manage diabetes.</li><li>âž¤ Alogliptin</li><li>âž¤ DPP-4 inhibitor</li><li>âž¤ Apremilast is a PDE-4 inhibitor used to reduce inflammation in psoriasis and psoriatic arthritis .</li><li>âž¤ Apremilast</li><li>âž¤ PDE-4 inhibitor</li><li>âž¤ psoriasis</li><li>âž¤ psoriatic arthritis</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 31-year-old woman at 33 weeks gestation presents for a routine ultrasound. The ultrasound shows fetal growth restriction, and Doppler studies are performed. Which of the following Doppler findings is not an indication for immediate delivery in a fetus with growth restriction?", "options": [{"label": "A", "text": "Absent end diastolic flow in the umbilical artery", "correct": false}, {"label": "B", "text": "Reversal of a wave in the ductus venosus", "correct": false}, {"label": "C", "text": "Pulsatility of the umbilical vein", "correct": false}, {"label": "D", "text": "Decreased pulsatility index (PI) of the uterine artery", "correct": true}], "correct_answer": "D. Decreased pulsatility index (PI) of the uterine artery", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Decreased pulsatility index (PI) of the uterine artery</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ In fetal growth restriction (FGR), decreased pulsatility index (PI) of the uterine artery is not an indication for immediate delivery. Critical Doppler findings that do suggest the need for immediate delivery include absent end diastolic flow in the umbilical artery , reversal of a wave in the ductus venosus , and pulsatility of the umbilical vein , all of which indicate significant fetal compromise.</li><li>âž¤ In fetal growth restriction (FGR), decreased pulsatility index (PI) of the uterine artery is not an indication for immediate delivery.</li><li>âž¤ decreased pulsatility index (PI) of the uterine artery</li><li>âž¤ Critical Doppler findings that do suggest the need for immediate delivery include absent end diastolic flow in the umbilical artery , reversal of a wave in the ductus venosus , and pulsatility of the umbilical vein , all of which indicate significant fetal compromise.</li><li>âž¤ absent end diastolic flow in the umbilical artery</li><li>âž¤ reversal of a wave in the ductus venosus</li><li>âž¤ pulsatility of the umbilical vein</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 65-year-old man is scheduled for elective surgery and requires a blood transfusion. To ensure the availability of compatible blood, the blood bank must store the donated blood units for several weeks before the procedure. The staff chooses a preservative solution that allows the blood to be stored for up to 35 days while maintaining cell viability. Which of the following preservatives is most appropriate for this purpose?", "options": [{"label": "A", "text": "Acid Citrate Dextrose", "correct": false}, {"label": "B", "text": "Citrate Phosphate Double Dextrose", "correct": false}, {"label": "C", "text": "Lithium heparin", "correct": false}, {"label": "D", "text": "Citrate Phosphate Dextrose Adenine-1 (CPDA-1)", "correct": true}], "correct_answer": "D. Citrate Phosphate Dextrose Adenine-1 (CPDA-1)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. D) Citrate Phosphate Dextrose Adenine-1 (CPDA-1)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ CPDA-1 allows blood storage for up to 35 days by maintaining red blood cell viability and ATP levels.</li><li>âž¤ CPDA-1 allows blood storage for up to 35 days by maintaining red blood cell viability and ATP levels.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 28-year-old woman with one previous live birth presents to your clinic inquiring about the contraceptive implant, Implanon NXT, for long-term contraception. Which of the following is an absolute contraindication to using this contraceptive method?", "options": [{"label": "A", "text": "Thromboembolic disease", "correct": false}, {"label": "B", "text": "Breast cancer", "correct": true}, {"label": "C", "text": "Cervical cancer", "correct": false}, {"label": "D", "text": "Recent cesarean delivery in a lactating woman", "correct": false}], "correct_answer": "B. Breast cancer", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Breast cancer</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Breast cancer is an absolute contraindication to the use of hormonal contraceptives, including Implanon NXT, because of the potential for hormone-driven tumor growth. Progestin-only contraceptives are generally safe in patients without contraindications like breast cancer.</li><li>âž¤ Breast cancer is an absolute contraindication to the use of hormonal contraceptives, including Implanon NXT, because of the potential for hormone-driven tumor growth.</li><li>âž¤ Breast cancer</li><li>âž¤ absolute contraindication</li><li>âž¤ Progestin-only contraceptives are generally safe in patients without contraindications like breast cancer.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 45-year-old woman is prescribed a proton pump inhibitor (PPI) for chronic gastroesophageal reflux disease (GERD). The medication is provided as an enteric-coated tablet to ensure proper absorption. Which of the following is not an advantage of using enteric-coated tablets for drug delivery?", "options": [{"label": "A", "text": "Protects the acid-labile drug from gastric acidity", "correct": false}, {"label": "B", "text": "Protects the gastric mucosa from irritant effects of certain drugs", "correct": false}, {"label": "C", "text": "Prolongs the half-life of the drug", "correct": true}, {"label": "D", "text": "Delivers drugs distal to the stomach", "correct": false}], "correct_answer": "C. Prolongs the half-life of the drug", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Prolongs the half-life of the drug</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Enteric coating is used to protect acid-labile drugs from gastric acidity , protect the stomach lining , and target drug delivery to the intestine . Enteric coating does not affect the drugâ€™s half-life , which is influenced by metabolic and elimination pathways in the body.</li><li>âž¤ Enteric coating is used to protect acid-labile drugs from gastric acidity , protect the stomach lining , and target drug delivery to the intestine .</li><li>âž¤ Enteric coating</li><li>âž¤ protect acid-labile drugs</li><li>âž¤ gastric acidity</li><li>âž¤ protect the stomach lining</li><li>âž¤ target drug delivery</li><li>âž¤ intestine</li><li>âž¤ Enteric coating does not affect the drugâ€™s half-life , which is influenced by metabolic and elimination pathways in the body.</li><li>âž¤ Enteric coating does not affect the drugâ€™s half-life</li><li>âž¤ metabolic</li><li>âž¤ elimination pathways</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 25-year-old patient develops skin rashes after coming into contact with poison ivy while hiking. Which type of hypersensitivity reaction is most likely responsible for his symptoms, and what is the primary mechanism involved?", "options": [{"label": "A", "text": "Type I - IgE-mediated mast cell degranulation", "correct": false}, {"label": "B", "text": "Type II - Antibody-dependent cell lysis", "correct": false}, {"label": "C", "text": "Type III - Immune complex deposition", "correct": false}, {"label": "D", "text": "Type IV - T-cell mediated activation of macrophages and cytotoxic T cells", "correct": true}], "correct_answer": "D. Type IV - T-cell mediated activation of macrophages and cytotoxic T cells", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/21/screenshot-2024-10-21-135801.jpg"], "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 27-year-old woman with a history of systemic lupus erythematosus (SLE) presents with new-onset headaches, blurred vision, and hypertension. Fundoscopic examination shows flame-shaped hemorrhages and cotton-wool spots consistent with hypertensive retinopathy. She has previously been treated with corticosteroids for lupus nephritis, but her renal function has worsened. A renal biopsy shows wire-loop lesions and extensive immune complex deposition in the glomeruli. Which of the following autoantibodies is most specific for this patientâ€™s lupus-related renal pathology?", "options": [{"label": "A", "text": "Anti-nuclear antibody (ANA)", "correct": false}, {"label": "B", "text": "Anti-Ro/SSA antibody", "correct": false}, {"label": "C", "text": "Anti-double-stranded DNA (anti-dsDNA) antibody", "correct": true}, {"label": "D", "text": "Anti-histone antibody", "correct": false}], "correct_answer": "C. Anti-double-stranded DNA (anti-dsDNA) antibody", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Anti-double-stranded DNA (anti-dsDNA) antibody</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Anti-double-stranded DNA (anti-dsDNA) antibodies are highly specific for systemic lupus erythematosus (SLE) and are strongly associated with lupus nephritis , making them a key marker for renal involvement in SLE.</li><li>âž¤ Anti-double-stranded DNA (anti-dsDNA) antibodies are highly specific for systemic lupus erythematosus (SLE) and are strongly associated with lupus nephritis , making them a key marker for renal involvement in SLE.</li><li>âž¤ Anti-double-stranded DNA (anti-dsDNA) antibodies</li><li>âž¤ systemic lupus erythematosus (SLE)</li><li>âž¤ lupus nephritis</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 45-year-old lady presents to the emergency department with severe abdominal pain. An abdominal ultrasound reveals the presence of multiple gallstones with no evidence of wall thickening. The bile duct (BD) diameter is measured at 12 mm, and serum bilirubin levels are elevated at 2.8. The patient